MIRA Pharmaceuticals, Inc. Common Stock (MIRA)

MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is a Drug Manufacturers - General company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $28M; returns 1 day -1.5%, 1 week -2.0%, 1 year -60.0%.

MIRA Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for neurologic and neuropsychiatric disorders. As a pre-revenue entity, its business model is entirely centered on the research and development of its pipeline candidates with the goal of future commercialization upon FDA approval.

Groups MIRA belongs to

• Clinical Stage Biopharma
• Biotechnology
• Biopharmaceutical
• Pharmaceuticals
• Neuroscience
• Neurological Disorders
• CNS Disorders
• Weight Management
• Pain Management
• Mental Health Solutions
• Healthcare
• R&D

MIRA financial model: income statement, cash flow and balance sheet